192 related articles for article (PubMed ID: 33815427)
1. Editorial: Immune Mechanisms in the Pathologic Response to Particles, Fibers, and Nanomaterials.
Ma Q; Pollard KM; Brown JM; Italiani P; Moghimi SM
Front Immunol; 2021; 12():665810. PubMed ID: 33815427
[No Abstract] [Full Text] [Related]
2. Cytokines as biomarkers of nanoparticle immunotoxicity.
Elsabahy M; Wooley KL
Chem Soc Rev; 2013 Jun; 42(12):5552-76. PubMed ID: 23549679
[TBL] [Abstract][Full Text] [Related]
3. Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.
David CA; Owen A; Liptrott NJ
Nanomedicine (Lond); 2016 Jun; 11(11):1447-64. PubMed ID: 27171671
[TBL] [Abstract][Full Text] [Related]
4. From immunotoxicity to nanotherapy: the effects of nanomaterials on the immune system.
Smith MJ; Brown JM; Zamboni WC; Walker NJ
Toxicol Sci; 2014 Apr; 138(2):249-55. PubMed ID: 24431216
[TBL] [Abstract][Full Text] [Related]
5. A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements.
Giannakou C; Park MV; de Jong WH; van Loveren H; Vandebriel RJ; Geertsma RE
Int J Nanomedicine; 2016; 11():2935-52. PubMed ID: 27382281
[TBL] [Abstract][Full Text] [Related]
6. Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls.
Giannakou C; Park MVDZ; Bosselaers IEM; de Jong WH; van der Laan JW; van Loveren H; Vandebriel RJ; Geertsma RE
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1633. PubMed ID: 32266791
[TBL] [Abstract][Full Text] [Related]
7. Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives.
Poh TY; Ali NABM; Mac Aogáin M; Kathawala MH; Setyawati MI; Ng KW; Chotirmall SH
Part Fibre Toxicol; 2018 Nov; 15(1):46. PubMed ID: 30458822
[TBL] [Abstract][Full Text] [Related]
8. Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing?
Dusinska M; Tulinska J; El Yamani N; Kuricova M; Liskova A; Rollerova E; Rundén-Pran E; Smolkova B
Food Chem Toxicol; 2017 Nov; 109(Pt 1):797-811. PubMed ID: 28847762
[TBL] [Abstract][Full Text] [Related]
9. Engineered Nanomaterials for Immunomodulation: A Review.
Singh R; Kumawat M; Gogoi H; Madhyastha H; Lichtfouse E; Daima HK
ACS Appl Bio Mater; 2024 Feb; 7(2):727-751. PubMed ID: 38166376
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility and nanostructured materials: applications in nanomedicine.
Adabi M; Naghibzadeh M; Adabi M; Zarrinfard MA; Esnaashari SS; Seifalian AM; Faridi-Majidi R; Tanimowo Aiyelabegan H; Ghanbari H
Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):833-842. PubMed ID: 27247194
[TBL] [Abstract][Full Text] [Related]
11. Interactions of nanomaterials with the immune system.
Hussain S; Vanoirbeek JA; Hoet PH
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(2):169-83. PubMed ID: 22144008
[TBL] [Abstract][Full Text] [Related]
12. EDITORIAL: Medicinal Chemistry of Nanomaterials for Cancer Theranostics.
Liang F; Zhang C
Curr Top Med Chem; 2017; 17(16):1803-1804. PubMed ID: 28589852
[No Abstract] [Full Text] [Related]
13. Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation.
Wang X; Reece SP; Brown JM
Toxicol Mech Methods; 2013 Mar; 23(3):168-77. PubMed ID: 23256453
[TBL] [Abstract][Full Text] [Related]
14. Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy.
Dobrovolskaia MA
J Control Release; 2015 Dec; 220(Pt B):571-83. PubMed ID: 26348388
[TBL] [Abstract][Full Text] [Related]
15. Application of Metallic Nanomaterials in Nanomedicine.
Singh MR
Adv Exp Med Biol; 2018; 1052():83-102. PubMed ID: 29785483
[TBL] [Abstract][Full Text] [Related]
16. Toxic potential of materials at the nanolevel.
Nel A; Xia T; Mädler L; Li N
Science; 2006 Feb; 311(5761):622-7. PubMed ID: 16456071
[TBL] [Abstract][Full Text] [Related]
17. Insights into the toxicological effects of nanomaterials on atherosclerosis: mechanisms involved and influence factors.
Chen S; Su Y; Zhang M; Zhang Y; Xiu P; Luo W; Zhang Q; Zhang X; Liang H; Lee AP; Shao L; Xiu J
J Nanobiotechnology; 2023 Apr; 21(1):140. PubMed ID: 37118804
[TBL] [Abstract][Full Text] [Related]
18. Assessing the effect of engineered nanomaterials on the environment and human health.
Geary SM; Morris AS; Salem AK
J Allergy Clin Immunol; 2016 Aug; 138(2):405-8. PubMed ID: 27497279
[No Abstract] [Full Text] [Related]
19. The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM).
Westmeier D; Stauber RH; Docter D
Toxicol Appl Pharmacol; 2016 May; 299():53-7. PubMed ID: 26592323
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery.
Palombo M; Deshmukh M; Myers D; Gao J; Szekely Z; Sinko PJ
Annu Rev Pharmacol Toxicol; 2014; 54():581-98. PubMed ID: 24160695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
